Menopause is the permanent cessation of menstruation that results from depletion of ovarian germ cells and follicles. Although most animals experience reproductive senescence, the mechanisms differ from that in women, who may live more than one-third of their lives after menopause and consequently face the risk of a number of menopause-associated health problems. Understanding factors that influence ovarian aging may provide strategies to delay or alleviate physiological alterations that take place in postmenopausal women. The germ cell-deficient Wv mice recapitulate follicle loss, prolong postreproductive lifespan, and model many physiological changes that take place in postmenopausal women. Here, using genetic and pharmacological approaches, we found that inhibition of cyclooxygenase-1 but not cyclooxygenase-2 in Wv mice delays germ cell depletion and preserves ovarian follicles. Cyclooxygenase-1 inhibition slows down follicle maturation at the conversion of primary to secondary follicles and prolongs postnatal ovarian follicle lifespan. The current study suggests that inhibition of cyclooxygenase-1 may be able to delay ovarian aging and modulate menopausal timing.
INTRODUCTION
Menopause marks the time when the menstrual cycle ceases due to the depletion of the pool of ovarian follicles and clearly signals the end of a woman's reproductive lifetime. The average age of menopause in Western countries is 51 yr, but can range from 40 to 60 yr [1] . Human females may live onethird or more of their lives after menopause and consequently face the risk of a number of major health problems that result from dramatic hormonal and metabolic changes, which follow the loss of ovarian follicular function. These include bone and muscle loss, excess fat deposition, cognitive decline, cardiovascular disorders, and increased risk for certain cancers, including ovarian cancer [2] .
Although accelerated ovarian follicle depletion marks the transition to menopause, the process leading up to reproductive senescence is complex, beginning before birth and continuing for decades [3] . In mammals, the finite population of oocytes found in the reproductively mature ovary is established during embryogenesis when the primordial germ cells undergo mitotic division and form oogonia. The cells arrest at the diplotene stage of meiosis I as primary oocytes, a stationary phase in which they remain until shortly before ovulation [4] . Follicles form in late embryogenesis for humans and the immediate neonatal period for mice, when the oocytes become surrounded by granulosa cells, a basement membrane, and an outer layer of theca cells. Most oocytes are progressively lost by atresia, or apoptosis, which is thought to be the major cause of follicle depletion resulting in menopause [5, 6] . Thus, factors that regulate the initial endowment of oocytes, the rate of ovarian follicle maturation and survival relative to atresia, as well as the quality of the oocytes will affect reproductive aging and menopausal timing. Environmental factors, such as smoking and diet [7] , and a definite genetic component [8, 9] can also influence the age at menopause in humans. Understanding how these many diverse mechanisms affect ovarian function and aging may reveal strategies to delay menopause or alleviate the health challenges often presenting in postmenopausal women [3] .
We have considered here the function of cyclooxygenase (COX) activity in reproductive senescence. In a number of systems, COX enzymes and downstream products are key regulators of female reproduction, particularly ovulation and implantation [10, 11] . In mammals, two COX enzymes catalyze the first committed step in the synthesis of prostaglandins (PGs) from arachidonic acid. COX-2 is the inducible enzyme upregulated by inflammation, cytokines, and growth factors, and genetic deletion of the gene encoding COX-2 (Ptgs2 in the mouse) results in infertility in mice [11, 12] , where cumulus activation, stigmata formation, and ovulation itself are impaired [13] , as well as implantation and decidualization [11] . In contrast, COX-1 (Ptgs1 in the mouse) is considered the so-called housekeeping PG synthase and is principally responsible for most tissue PG production, but it is not required for ovulation [14] . Deletion of COX-1, for example, decreased gastric PGE 2 levels by 99% but had no obvious effect on female reproduction, although parturition was found delayed in some COX-1 null mice [14] . In the present study, using genetic and pharmacological approaches, we observed that suppression of COX-1, but not COX-2, delayed germ cell depletion and preserved ovarian follicles in mice, including the Wv/Wv mice that model menopause. Inhibitors of COX-1 acted to slow down maturation at the conversion of primary to secondary follicles.
MATERIALS AND METHODS

Generation and Genotyping of Wv/Wv:COX-1 Mutant Mice
An inbreeding colony was established by crossing Wv/þ (C57BL/6J-Kit W-v/J , from Jackson Laboratory) and COX-1 (þ/À) mice (C57BL/6-129/Ola-) in the C57BL/6J background. We obtained three COX-1 (þ/À) mating pairs from Dr. R. Langenbach and colleagues (National Institute of Environmental Health Sciences, Research Triangle Park, NC). Littermates with Wv/þ:COX-1 (þ/À) genotype were further intercrossed to generate mutant and control mice for analysis. The Wv genotypes of the resulting progeny were identified by coat color: white, grayish-black with dorsal and/or ventral white spots, or black/ agouti represent Wv/Wv homozygous mutant, Wv/þ heterozygous mutant, or Wv (þ/þ) wild type (WT), respectively. It was important to distinguish white coat/black-eyed mice from albino or yellow coat/red-eyed mice that were derived from the 129 genetic background and had a WT ovarian phenotype. We also maintained a separate COX-1 mutant line in the WT C57BL/6J background, which have been listed as Wv WT:COX-1, (þ/þ), (þ/À), or (À/À), or simply as COX-1 mice. Mice were housed in microisolated, vented cages with free access to autoclaved water and Purina 5001 standard mouse chow in barricaded viral pathogen-free rooms, maintained at 228C-248C and under a 12L:12D cycle. All the animal procedures were approved by the University of Miami Miller School of Medicine IACUC committee and followed NIH guidelines.
For all the experiments, because adult Wv/Wv mice do not enter the estrous cycle, mice were selected based on the desired age and genotype. The stage of the estrous cycle was not determined for Wv WT or heterozygous mice.
Mouse COX genotypes were verified by PCR analysis using the genomic DNA isolated from mice using primers against exon 10 of the murine COX-1 (Ptgs1) gene and for the Neo gene [15, 16] : WT forward primer, 5 0 -AGG AGA TGG CTG CTG AGT TGG-3 0 ; knockout forward primer, 5 0 -GCA GCC TCT GTT CCA CAT ACA C-3 0 ; common reverse primer, 5 0 -AAT CTG ACT TTC TGA GTT GCC-3.
0 Reactions for PCR were set up in 25-ll total volume using 25-50 ng genomic DNA, 0.2 lM final primer concentration, GoTaq Green DNA polymerase master mix (Promega), and cycling conditions as specified [17] . Products from the PCR reactions of 601 bp and 646 bp, for WT and knockout, respectively, were resolved by electrophoresis on a 2% agarose gel containing ethidium bromide. To analyze COX-2 (Ptgs2) in COX-1/COX-2 mice, the primers were: COX2 D9, for the WT allele, 
Immunohistochemistry and Analysis and Quantitation of Tumor Phenotype
Ovaries were fixed in 10% buffered formalin and embedded in paraffin. The paraffin blocks were cut into 5-lm thick sections, which were placed on positively charged slides. The sections were dewaxed in xylene and hydrated through graded ethanol. Heat-induced antigen retrieval was then carried out in 10 mM sodium citrate buffer, pH 6.0, in a microwave initially set at high power setting (no. 10) for 2 min, followed by 10 min on low power setting (no. 2). Alternatively, antigen retrieval was performed for 20 min in a boiling water bath, followed by 20 min cool down before proceeding. The endogenous peroxidase activity was blocked by immersing the slides in 3% H 2 O 2 in methanol for 15 min. After 30 min incubation in blocking serum, 1% bovine serum albumin in PBS or Background Sniper (BioCare Medical), the slides were incubated with primary antibodies at 48C overnight at the following dilutions: rat monoclonal anti-Troma-1/cytokeratin-8 (Developmental Studies Hybridoma Bank at The University of Iowa) at 1:600 and goat polyclonal anti-PGC7 (R & D Systems) at 1:10 000. After extensive washing, the slides were incubated as appropriate with polyclonal rabbit anti-goat (or rat) immunoglobulin G-bridging antibody (1:500) for 35 min, followed by washing, and finally with a secondary horseradish peroxidase-labeled polymer anti-rabbit antibody (DAKO or Vector Laboratory) for 35 min at room temperature. Diaminobenzidine was used as the chromogen for the immunoperoxidase reaction. The slides were counterstained with hematoxylin and mounted in 50:50 xylene:Permount.
To determine the extent of tumor phenotype, the largest cross-section of an ovary was stained with cytokeratin-8 to identify epithelial components and a digital image was recorded. The degree of tumor phenotype was defined as the percentage of the ovary penetrated by the cytokeratin-8-positive epithelial tubular structure. This was determined by laying a 20 3 20 grid over the digital image of the ovary to divide the ovary into 200-300 squares. At least three individuals with no prior knowledge of the sample's genotype independently scored the squares as positive or negative for cytokeratin-8 staining. The three scores were averaged, and the mean was reported.
Preparation of Ovarian Lysates, Measurement of COX Activity, and Immunoblotting
Mouse ovaries were snap-frozen upon surgical removal and maintained at À808C until the tissues were utilized for protein analysis. To prepare ovarian lysates, frozen tissues were homogenized in either RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) for Western blots or 13 COX activity buffer (Cayman Chemical) for activity determination, using a Mini-BeadBeater (BioSpec Products) at 5000 rpm, three times at 20 sec interval, resting on ice between each cycle. Phosphatase and protease inhibitors were included in all the homogenization buffers. The protein concentration in the supernatant was measured using the Bio-Rad DC protein assay. For Western blot analysis, an aliquot of the total ovarian lysate was separated by electrophoresis on a 4%-12% gradient gel and electrotransferred onto a polyvinylidene fluoride membrane. Membranes were incubated with antibodies against either inhibin-alpha (Serotec), PGC7, COX-1 (Cayman Chemical), or COX-2 (Cayman Chemical) followed by horseradish peroxidase-labeled secondary antibodies (BioRad). The signals were revealed using a chemiluminescence detection system (Pierce). The relative intensity of selected protein bands on the Western blots was determined using NIH imageJ software. COX activity was determined using a fluorescence assay according to manufacturer's protocol (Cayman Chemical).
Analysis of Serum Follicle-Stimulating Hormone
Serum samples from control (Wv WT:
, and Wv/Wv:COX-1 (À/À) were collected by retroorbital bleed at the time of sacrifice and stored at À808C until analyzed. The follicle-stimulating hormone (FSH) level in the serum was measured by radioimmunoassay through a custom service from the National Hormone and Peptide Program (Harbor-UCLA Medical Center, Torrance, CA) or using ELISA-based spectrophotometric immunoassay kits from ALPCO Diagnostics, with similar results.
Drug Administration
Six-wk-old female Wv/Wv:COX-1 (þ/þ) mice, weighing around 14 g, were randomly allocated into three groups: nontreated control, indomethacintreated, or SC-560-treated groups. Indomethacin (6 lg/ml; Sigma-Aldrich) and SC-560 (0.05 mg/ml; Cayman Chemical) were introduced through drinking water, which was changed every 2-3 days. During the study, mice were permitted free access to chow and drinking water. All the mice were inspected once daily to monitor their general health status. Optimal dosage was estimated so that the mice received 30 lg/day for indomethacin and 0.2 mg/day for SC-560. Dosages double these amounts resulted in some toxicity such as reduced weight or activity/alertness in the female Wv/Wv mice. Mice were sacrificed after 2 mo of treatment at 3.5-4 mo of age. Ovarian tissues were collected and subjected to histopathological examination.
RESULTS
We noted somewhat incidentally that COX-1 knockout (COX-1 [À/À]) females appeared to be more persistent or longer breeders than their WT counterparts in the same C57BL/ 6J background. Female C57BL/6J mice are considered good breeders, producing three to seven pups per litter, though progeny number and reproductive performance usually diminish before 1 yr of age, based on long-time husbandry records [18] .
continuously from 2 mo of age until no pregnancies were observed for at least 2 mo, the COX-1 knockout mice had significantly more litters per female breeder (P 0.01) and on average one more pup per litter (P 0.01) as well as generally producing litters for 3-5 mo longer (P , 0.05). As a comparison, COX-2 (þ/À) heterozygous mice (because COX-2 homozygous mutant females are infertile) were poorer breeders, averaging only five pups per litter and only one to two pups in the terminal litter (n ¼ 9).
To understand how COX-1 suppression might affect reproductive longevity, we bred the Ptgs1 deletion into the Wv background, a mouse model of menopause [19] . Here, we found that deletion of COX-1 protein also reduced the SMITH ET AL.
formation of ovarian epithelial lesions in the Wv mice (Fig. 1) . As shown in Figure 1A , a WT (Wv WT:COX-1 [þ/þ]) ovary contained follicles at all stages of maturation and corpora lutea, steroid-producing structures that develop from the follicles following ovulation and serve as rather good indicators of the ovulatory capability of the ovary. Cytokeratin stained only the surface epithelium of the WT ovary. The Wv mouse ovary, however, was considerably smaller, devoid of detectable follicles at any stage, and infiltrated throughout with the cytokeratin-positive tubular adenomas. The Wv/Wv:COX-1 (À/À) ovaries had considerably reduced cytokeratin infiltration (Fig. 1A) (also shown in Supplemental Figure S1 ; all the supplemental data is available online at www.biolreprod.org).
Wv/Wv:COX-1 (þ/þ) ovaries had elevated expression of COX-1 protein (Fig. 1B) as well as a nearly around 5-fold increase in total COX activity over WT. Because this activity was not suppressed in the presence of a COX-2 specific inhibitor (DuP-697) (Fig. 1C) , COX-1 was presumably the principal cyclooxygenase activity in the ovary. Deletion of COX-1 reduced total COX activity in both the Wv WT and Wv/Wv ovaries, and the remaining COX activity in Wv/ Wv:COX-1 (À/À) lysates was presumably suppressed by the COX-2 inhibitor (Fig. 1C) . COX-2 expression varied somewhat in ovarian lysates prepared from different mice (Fig. 1B) , which may explain the measurable activity that remained in lysates from WT:COX-1 (À/À) and Wv/Wv:COX (À/À) ovaries. However, the average level of COX-2 protein when normalized to actin was not noticeably up-regulated in Wv/ Wv:COX-1 (À/À) ovaries (ratio of COX2:actin ¼ 0.99; n ¼ 5) (Fig. 1B) , confirming that COX-2 expression cannot fully compensate for COX-1. We also found that levels of PGC7 and inhibin-alpha, markers of germ and granulosa cells, respectively, increased in Wv/Wv:COX-1 (À/À) ovaries (Fig. 1D) . In contrast, serum FSH levels were reduced in Wv/Wv:COX-1 (À/À) mice relative to Wv/Wv:COX-1 (þ/þ) mice (Fig. 1E) possibly because FSH levels in the Wv/Wv mice rise as the result of loss of feedback inhibition by progesterone and estrogen produced by ovarian corpora lutea [20] . Because the mice were selected based on age and genotype and not on the stage of the estrous cycle, the variability of FSH levels observed in Wv WT (Wv WT:COX-1 [þ/þ]) mice reflects that some female mice were cycling. However, in Wv/Wv:COX-1 (þ/þ) and Wv/Wv:COX-1 (þ/À) mice, FSH levels were increased at least 3-to 4-fold over those of WT:COX-1 (þ/þ) mice, which supports that the mice had lost ovarian feedback regulation of FSH. The general decrease in FSH levels in the Wv/Wv:COX-1 (À/À) mice underpinned the idea that Wv/ Wv:COX-1 (À/À) mice may retain ovarian follicular function later than Wv/Wv mice. Lysates from dissected whole ovaries from each genotype were analyzed by Western blot for the presence of PGC7 and inhibin-alpha proteins. Actin expression was used as a loading control. E) Serum was collected from 3-to 4-mo-old mice and used to determine average FSH levels (nmol/mg) 6 SD. Significant differences relative to the control Wv/Wv:COX-1 (þ/þ) were determined using Student t-test, *P , 0.05 and **P , 0.0001.
COX-1 IN OVARIAN FOLLICLE LIFESPAN
To understand how suppression of COX-1 affects ovarian dynamics, we examined follicles in ovaries from mice at various ages. In our experiments, WT (Wv WT:COX-1 [þ/þ]) newborn ovaries (2-3 days after birth) contained greater than 100 distinct oocytes per widest cross-section, whereas both Wv/Wv:COX-1 (þ/þ) and Wv/Wv:COX-1 (À/À) ovaries had only 1-5 oocytes in a similar cross-section ( Fig. 2A) . This finding agrees with the number predicted based on the known reduction in cKit activity in Wv/Wv mice [21] .
We then examined ovaries from 1.5-mo-old mice, when the ovaries are functionally mature and the mice have just reached reproductive competency. Identification of follicles and oocytes followed the classification proposed by Pedersen and Peters [22] . The 1.5-mo WT ovaries contained follicles of all stages, including secondary preantral, antral, and corpora lutea, and numerous primordial and small growing primary follicles around the periphery (Fig. 2B, top panel) . Most follicles in the 1.5-mo-old Wv/Wv ovaries (Fig. 2B, middle panel) had advanced to the late secondary or antral phases but fewer were found within the smaller organ, which agrees with published findings [23, 24] . We did observe in some Wv/Wv ovaries small atypical cuboidal primary follicles, which have been described in other mutant cKit ovaries that completely lack cKit signaling and can be attributed to a function of cKit in primary follicle development [25, 26] . We also found a significant portion of larger and more mature follicles in the Wv/Wv ovary (P , 0.0001) (Fig. 2B) . In Wv/Wv:COX-1 (À/À) ovaries of the same age, although secondary and antral follicles and corpora lutea were observed, primary and preantral follicles constituted a greater fraction of the total follicles detected in the ovaries (Fig. 2, B, C, and D) . These follicles in the Wv/ Wv:COX-1 (À/À) ovaries tended to be the cuboidal type but were nevertheless more abundant. Importantly, however, we examined ovaries from COX-1 knockout mice that were WT for Wv (Wv WT:COX-1 [À/À]) and found a similar proportional increase in large primary follicles, in which follicles with an expanded oocyte surrounded by one to two layers of granulosa cells constituted a significant portion (approximately 20%) of the total follicles compared to COX-1 (þ/þ) WT (approximately 10%; P , 0.01) (Fig. 3) ; we did not observe a difference in the total number of detectable follicles. This would support that the deletion of COX-1 affects principally the same step of follicle maturation and development in either the Wv/Wv or WT background, the maturation of stage I follicles to early stage II follicles.
Next, we tested whether pharmacologic inhibition of COX-1 would have a similar effect as genetic suppression on follicle lifespan. Wv/Wv homozygous (Wv/Wv: WT:COX-1 (À/À) ovary from 1.5-mo-old mice are shown stained for PGC7 to mark the presence of germ cells. Magnification 340. C) Sections were stained with PGC7, and follicles were counted in similar sections for each ovary (n ¼ 4 each). Follicles were identified based on the size of the oocyte, the number of layers of granulosa cells, the presence of an antrum, or as corpus luteum, which was included as evidence of a prior follicle. Results for each follicle stage are expressed as the percent of the total number of counted follicles 6 SD. Significant differences between WT and COX-1 knockout were determined by the Student t-test, *P 0.01.
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were administered one of three cyclooxygenase inhibitors: indomethacin, a nonspecific but preferential COX-1 inhibitor; celebrex, a COX-2-specific inhibitor; or SC-560, a COX-1-specific inhibitor. Administration of the drug began at 4-6 wk of age, before tumor development is readily detectable, and continued until the mouse was 4-mo old. Both indomethacin and celebrex prevented formation of ovarian epithelial lesions (Fig. 4A ), in agreement with our prior finding [24] , though indomethacin seemed to be more effective. We found in 80% (10 out of 12) mice treated with the COX-1 inhibitors that small primary follicles were retained in the ovary (Fig. 4B and Table 1 ). No follicles were detected in the ovaries from celebrex-treated Wv/Wv mice, even in the ovaries that had reduced or no observable tumor lesions. Based on the single layer of granulosa cells surrounding the oocyte and the size of the oocyte (Fig. 4, C and D) , the follicles resembled those that predominated in Wv/Wv:COX-1 (À/À) ovaries at 1.5 mo.
It should be noted that Ptgs1 deletion delayed ovarian aging but does not prevent it. By 1 yr of age, most Wv/Wv:COX-1 (À/À) ovaries were indistinguishable from Wv/Wv:COX-1 (þ/þ) ovaries, though we did find some aged Wv/Wv:COX-1 (À/À) ovaries that lacked significant epithelial lesion development (Fig. 5) . At this time, ovaries had been depleted of follicles and epithelial tubular adenomas fully permeated the ovaries. Cyclooxygenase inhibitors administered after the tubular adenomas form do not reverse or rescue the epithelial phenotype [24] .
DISCUSSION
In our study, we found that genetic deletion and pharmacological suppression of COX-1 in the Wv/Wv background delayed follicle depletion and ovarian aging. Based on the morphology of the oocyte and follicle, COX-1 suppression appears to delay the progression of primary to secondary follicles and thus reduces the rate of follicle loss, the ultimate cause of menopause. COX-1 is targeted by aspirin and other nonsteroidal anti-inflammatory drugs, and our observations may suggest the possibility of using pharmacological agents to modulate reproductive aging.
We have characterized the Wv (white spotting variant) mouse previously as a model of menopause. The Wv mouse line has a single point mutation in the kinase domain of the cKit receptor [20, 21, 27] , which is active in primordial germs cells, such that proliferation and migration of germ cells in the embryo are significantly reduced and the ovaries of Wv/Wv mice have about 1%-5% of the normal number of germ cells at birth compared to WT mice [28, 29] . The few germ cells remaining in the Wv/Wv ovaries are depleted within 2 mo of birth, and ovulation ceases to occur. The ovaries of adult Wv 
a Epithelial lesions were scored as following: þþþ, lesions significant in . 80% ovarian area; þþ, lesions significant in 40%-80% ovarian area; þ, lesions cover 20%-40% of ovarian area; þ/À, lesions extend into 0%-20% of ovarian area; À, not detected. The number in parentheses indicates the percentage of specimens containing any detectable epithelial lesions. b Ovarian follicle counts: þ/À, few (1-10 per immunohistochemistry section); À, none detected. At least four nonconsecutive sections were examined for each sample. COX-1 IN OVARIAN FOLLICLE LIFESPAN mutant mice develop pronounced epithelial morphological changes, including surface invaginations, inclusion cysts, papillomatosis, and benign ovarian tumors, known as tubular adenomas that infiltrate the ovary by 3 mo of age [19] [20] [21] 30] . The tumors originate from the ovarian surface and resemble changes found in human ovaries that may result from aging [24, 31] . The Wv females model several features of menopause in addition to follicle depletion and morphological ovarian aging, including elevated levels of gonadotropins (luteinizing hormone and FSH), altered serum levels of cholesterol and steroid hormones, decreased bone density, and reduced cardiac function [19] . We found previously that Wv/Wv ovaries have 2-fold or greater ovarian production of PGE 2 than WT littermates, and a reduction in COX-2 gene dosage reduced the extent of the ovarian lesions in the Wv mice [24] , yet the COX-2 homozygous mutant (Wv/Wv:COX-2 [À/À]) genotype was less effective in rescuing the tumor phenotype than the heterozygous mouse (Wv/Wv:COX-2 [þ/À]) (also shown in Supplemental Figure S1 ). This difference was attributed to the increased expression of COX-1 in the COX-2 knockout [24] . Our current study confirms that COX-1 expression correlates directly with the extent of the epithelial tumors that develop in the Wv/Wv ovaries. Suppression of COX-1 appears to act via two mechanisms to delay ovarian aging.
Because we did not find greater numbers of PGC7-positive germ cells in newborn ovaries, deletion of COX-1 did not rescue the underlying failure of the primordial germ cells to survive and migrate from the yolk sac into the gonadal ridge around Gestational Day 11-11.5 [28, 29, 32] . Thus, COX-1 deletion did not restore the initial ovarian reserve of oocytes. Rather, we found that COX-1 suppression delayed the depletion of the existing oocytes. In Wv/Wv:COX-1 (À/À) ovaries, follicles persisted in the large primary stage longer before progressing to secondary/antral stage. In Wv/Wv:COX-1 (þ/þ) ovaries, which do retain some cKit activity, follicles can continue the maturation process, as shown by the number of secondary/antral and corpus luteumlike structures in 1.5-mo ovaries (Fig. 2B) ; moreover, oocytes in the Wv/Wv mice do undergo ovulation, and in rare instances Wv mice have been reported to deliver full-term live pups [29] .
Other results supported that COX-1 suppression inhibited follicle depletion. Serum FSH levels in Wv/Wv:COX-1 (À/À) mice of 4 mo of age were reduced compared to Wv/Wv:COX-1 (þ/þ) and Wv/Wv:COX-1 (þ/À). FSH levels rise in menopause as a result of loss of feedback inhibition by progesterone produced from the corpora lutea, the steroidproducing structures that develop from the ovulated follicle. When follicles are depleted, ovulation ceases, and progesterone and estrogen levels decline and remain low. FSH levels then rise and remain elevated throughout menopausal years [33, 34] . The general decrease in serum FSH in Wv/Wv:COX-1 (À/À) mice supports the conclusion that the ovaries retain follicles and function longer than Wv/Wv:COX-1 (þ/þ) mice.
Additionally, COX-1 (À/À) mouse ovaries contained an increased number of primary follicles in either the Wv/Wv and WT genetic background. We did observe in some Wv/Wv ovaries small atypical cuboidal primary follicles, shown in Figure 2 , B and C, which have been described in other mutant cKit ovaries and attributed to a function of cKit in primary follicle development [25, 26] . Similarly, inhibition of COX-1 by indomethacin or SC-560 also preserved follicles at the same stage. The detection of follicles in the ovary of 4-mo-old Wv/ Wv female mice was quite remarkable because in over 300 ovaries examined in all our studies involving Wv mice, we have never observed any follicular structure in mature tumorbearing Wv/Wv ovaries. Furthermore, because the inhibitor was administered near sexual maturation, the results agree with the mechanism that COX-1 inhibition prolongs the survival of the existing follicle pool, rather than expands the initial follicle number.
We also observed a similar increase in the number of primary follicles containing an expanded oocyte in COX-1 (À/À) mutant ovaries in the WT background, with normal cKit activity (Fig. 3) . Thus, COX-1 suppression appears to affect the same step in follicle progression in both WT and Wv mice. Moreover, the Wv WT:COX-1 (À/À) female mice bred longer and more productively, again supporting the conclusion that COX-1 deletion extended the follicle lifespan or ovarian reserve. COX-1 activity is not required for ovulation, although it may have diverse actions in ovarian follicle development, maturation, and maintenance [11, 14, [35] [36] [37] . Moreover, the function may be evolutionarily similar to COX-1 action in Drosophila oogenesis in which COX activity is required to complete the distal portion of follicular development and maturation [38] . The ovary maintains a remarkable, precise coordination between the oocyte and supporting cells of the follicle to produce an egg viable and capable of fertilization [39] , in which the oocyte affects metabolic pathways in the follicle cells that regulate follicle development, and conversely the follicle cells influence oocyte maturation. Because PGs derived from COX activity are known as local, short-range hormones that function in maintaining local homeostasis [35] and can act through specific receptors that are encoded by different genes and elicit different signaling pathways [36] , COX-1 could influence follicle maturation at the level of the oocyte, granulosa or theca cells, or even via epithelial cells. Receptors for PGE 2 are found in the oocyte in preantral follicles [36] , and PGs have been found to stimulate proliferation of cultured theca external and granulosa cells isolated from chicken prehierarchical follicles [35, 37] . Thus, how COX-1 activity affects follicle maturation may well likely be at multiple cell types within the ovary.
As a second means of influencing ovarian aging, COX-1 activity may affect epithelial proliferation directly. Prostaglandins are known to function in some cells, such as carcinoma cells of the colon [40, 41] and ovary [42] , to stimulate proliferation and modulate apoptosis, and epidemiological evidence suggests that COX inhibition may reduce the risk of epithelial ovarian cancer by 40% or more [43] . Overexpression of COX-1, but not COX-2, is found in all stages of ovarian cancer and may be a general characteristic of epithelial ovarian cancer [44, 45] . Our findings corroborate that COX-1 expression and activity function in epithelial proliferation because Wv/Wv epithelial lesions are significantly reduced, even long-term, by COX-1 genetic and pharmacological suppression. Expression of COX-1 is elevated in Wv/Wv ovaries, possibly stimulated by the elevated levels of serum gonadotropins, which are thought to induce the tubular adenomas in the Wv mice [46] . However, most epidemiological studies that have explored the beneficial effects of COX inhibitors, such as aspirin [47] and nonsteroidal anti-inflammatory drugs, on reducing ovarian cancer risk have generally looked at postmenopausal women, and no systematic study has examined the perhaps more subtle effects of cyclooxygenase activity on general follicle development and preservation. The implications are significant because follicle preservation clearly affects ovarian function and general health. Our observations suggest the possibility of using pharmacological agents to modulate reproductive aging. SMITH ET AL.
